CCNB1, CCNB2, CCNA1, CCNA2, SYT1, SYT2, CKS2, CKS1B, CCNB3, SKP1, CDK1, RPS23, RPS27A, ZFAND4, RPS27, RPS27l, BUB1, BUB1B could play significant roles
| AUTHOR | Neville, John |
| PUBLISHER | Lulu.com (12/18/2017) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
Fourteen genes and their paralogues (CCNB1, CCNB2, CCNA1, CCNA2, SYT1, SYT2, CKS2, CKS1b, CCNB3, RPS23, RPS27A, ZFAND4, RPS27, RPS27l, BUB1, BUB1B, SKP1, CDK1), which putatively act as points of contact between ALDH18A1 and COP2 associated genes, particularly SEC23IP and CSNK1D, are identified which could play significant roles in the aetiology of schizophrenia. Many of these genes are found at the same genetic locations as deletion/duplication disorders and/or CNVs that have been reported on as being associated with schizophrenia. A partial failure of SEC23IP binding is identified as a possible cause of symptoms of 22q Parkinson's disease. Proline residues are identified as possible treatment targets in 22q Parkinson's disease.
Show More
Product Format
Product Details
ISBN-13:
9780244656096
ISBN-10:
0244656096
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
English
More Product Details
Page Count:
34
Carton Quantity:
240
Product Dimensions:
5.83 x 0.07 x 8.27 inches
Weight:
0.12 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Science | General
Descriptions, Reviews, Etc.
publisher marketing
Fourteen genes and their paralogues (CCNB1, CCNB2, CCNA1, CCNA2, SYT1, SYT2, CKS2, CKS1b, CCNB3, RPS23, RPS27A, ZFAND4, RPS27, RPS27l, BUB1, BUB1B, SKP1, CDK1), which putatively act as points of contact between ALDH18A1 and COP2 associated genes, particularly SEC23IP and CSNK1D, are identified which could play significant roles in the aetiology of schizophrenia. Many of these genes are found at the same genetic locations as deletion/duplication disorders and/or CNVs that have been reported on as being associated with schizophrenia. A partial failure of SEC23IP binding is identified as a possible cause of symptoms of 22q Parkinson's disease. Proline residues are identified as possible treatment targets in 22q Parkinson's disease.
Show More
List Price $5.50
Your Price
$5.22
